Trial · NCT03470441
Results by group140
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 140
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Arrhythmias of Interest, 48 Hours (Overall) | Experimental FDY-5301 Low Dose | Ventricular Fibrillation | 0 | participants | |
| Arrhythmias of Interest, 48 Hours (Overall) | Experimental FDY-5301 Intermediate Dose | Ventricular Fibrillation | 0 | participants | |
| Arrhythmias of Interest, 48 Hours (Overall) | Experimental FDY-5301 High Dose | Ventricular Fibrillation | 0 | participants | |
| Arrhythmias of Interest, 48 Hours (Overall) | Placebo | Ventricular Fibrillation | 0 | participants | |
| Arrhythmias of Interest, 48 Hours (Overall) | Experimental FDY-5301 Low Dose | Sustained Ventricular Tachycardia | 0 | participants | |
| Arrhythmias of Interest, 48 Hours (Overall) | Experimental FDY-5301 Intermediate Dose | Sustained Ventricular Tachycardia | 0 | participants | |
| Arrhythmias of Interest, 48 Hours (Overall) | Experimental FDY-5301 High Dose | Sustained Ventricular Tachycardia | 0 | participants | |
| Arrhythmias of Interest, 48 Hours (Overall) | Placebo | Sustained Ventricular Tachycardia | 0 | participants | |
| Arrhythmias of Interest, 48 Hours (Overall) | Experimental FDY-5301 Low Dose | Non-Sustained Ventricular Tachycardia | 1 | participants | |
| Arrhythmias of Interest, 48 Hours (Overall) | Experimental FDY-5301 Intermediate Dose | Non-Sustained Ventricular Tachycardia | 1 | participants | |
| Arrhythmias of Interest, 48 Hours (Overall) | Experimental FDY-5301 High Dose | Non-Sustained Ventricular Tachycardia | 7 | participants | |
| Arrhythmias of Interest, 48 Hours (Overall) | Placebo | Non-Sustained Ventricular Tachycardia | 2 | participants | |
| Arrhythmias of Interest, 48 Hours (Overall) | Experimental FDY-5301 Low Dose | High-Degree AV Block | 0 | participants | |
| Arrhythmias of Interest, 48 Hours (Overall) | Experimental FDY-5301 Intermediate Dose | High-Degree AV Block | 0 | participants | |
| Arrhythmias of Interest, 48 Hours (Overall) | Experimental FDY-5301 High Dose | High-Degree AV Block | 2 | participants | |
| Arrhythmias of Interest, 48 Hours (Overall) | Placebo | High-Degree AV Block | 0 | participants | |
| Arrhythmias of Interest, 48 Hours (Overall) | Experimental FDY-5301 Low Dose | Atrial Fibrillation | 0 | participants | |
| Arrhythmias of Interest, 48 Hours (Overall) | Experimental FDY-5301 Intermediate Dose | Atrial Fibrillation | 2 | participants | |
| Arrhythmias of Interest, 48 Hours (Overall) | Experimental FDY-5301 High Dose | Atrial Fibrillation | 1 | participants | |
| Arrhythmias of Interest, 48 Hours (Overall) | Placebo | Atrial Fibrillation | 1 | participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03470441/results